Depo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge

First group of pilot Depo-Provera cases in federal multidistrict litigation could be ready to go to trial by late 2026 or early 2027.

As a growing number of women continue to file Depo-Provera lawsuits over the development of meningioma brain tumors, the U.S. District Judge recently appointed to preside over the litigation has outlined the timeline for preparing a group of five “pilot” cases for early trials, in hopes of resolving the litigation quickly.

Although the Depo-Provera birth control shot has been on the market for more than 30 years, with millions of women having received the quarterly birth control injections to prevent pregnancy, there is now growing evidence that women may face an increased risk of developing brain tumors after receiving the injections.

Following the publication of studies last year, lawsuits have been filed by women throughout the U.S., each raising similar allegations that users and the medical community were not adequately warned that side effects of Depo-Provera may cause brain tumors. However, as more women learn about the cause of their injuries, it is widely expected that thousands of claims may ultimately be pursued.

Given common questions of fact and law raised in complaints filed in federal courts nationwide, a Depo-Provera MDL (multidistrict litigation) was established last month, centralizing claims before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida, for coordinated discovery and pretrial proceedings. 

Early in the MDL proceedings, Judge Rodgers identified five pilot Depo-Provera cases, which will go through case-specific discovery and motions to gauge how the Court and juries will respond to certain evidence and testimony that will be repeated throughout the litigation.

The Court issued a Case Management Order (PDF) on March 18, outlining the Depo-Provera lawsuit timeline for preparing these pilot cases for trial.

Judge Rodgers indicated that the parties have been working together closely and cooperatively, which is helping the litigation move swiftly. Therefore, she established a list of target deadlines in the litigation, with fact discovery set to begin this week.

According to the Depo-Provera lawsuit timeline outlined in the order:

• 3/27/2025 – Discovery opens
• 8/24/2025 – Deadline for summary judgment regarding preemption
• 9/23/2025 – Close of general causation discovery on link between Depo-Provera and meningioma
• 2/10/2026 – Deadline for motions to exclude expert witnesses regarding general causation

The parties are then expected to file a series of pretrial motions challenging the admissibility of certain evidence and testimony, which the court will address before the first Depo-Provera lawsuits go before a jury.

Depo-Provera Litigation Progressing Quickly

Judge Rodgers has made it clear since she was appointed that she is intent on pushing the parties toward a quick and efficient resolution for the litigation. Typically in MDL proceedings, it can take months or even years for the parties to jointly agree on a group of representative claims for early trial dates. Therefore, Judge Rodgers independently selected the five pilot cases weeks after she was appointed.

On March 15, Judge Rodgers issued a case management order that allowed direct filing in the litigation, and indicated that the parties will not go through the usual process of drafting a master complaint and short-form complaints. In addition, the Court indicated that the MDL will not involve a “Science Day,” which is typically scheduled early in MDL proceedings to bring the Court up to speed on the complex issues that will come up during the litigation.

Just a day later, she appointed 63 Depo-Provera attorneys to serve in leadership positions in the litigation.

With the Depo-Provera lawsuit timeline the Judge has laid out, the first trials may get underway by late 2026 or early 2027.

Although the outcomes of these trials will be not binding on other Depo-Provera lawsuits, they will give the parties a chance to see how juries respond to arguments and testimony that will be repeated throughout the litigation, which may help the parties reach Depo-Provera settlement agreements.